Elevation Oncology Inc
NASDAQ:ELEV
Elevation Oncology Inc
NASDAQ:ELEV
Price:
0.365
USD
-2.12%
Market Closed
Market Cap:
$21.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Elevation Oncology Inc
NASDAQ:ELEV
|
US |
|
Tuniu Corp
NASDAQ:TOUR
|
CN |
|
5N Plus Inc
TSX:VNP
|
CA |
|
M
|
Maruyama MFG Co Inc
TSE:6316
|
JP |
Balance Sheet
Balance Sheet Decomposition
Elevation Oncology Inc
Elevation Oncology Inc
Balance Sheet Decomposition is not available for
Elevation Oncology Inc
Elevation Oncology Inc
Balance Sheet
Elevation Oncology Inc
Elevation Oncology Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
2
|
79
|
146
|
46
|
49
|
49
|
|
| Cash Equivalents |
2
|
79
|
146
|
46
|
49
|
49
|
|
| Short-Term Investments |
0
|
0
|
0
|
44
|
34
|
44
|
|
| Other Current Assets |
0
|
1
|
3
|
3
|
5
|
2
|
|
| Total Current Assets |
2
|
81
|
149
|
93
|
88
|
95
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Assets |
2
N/A
|
81
+4 158%
|
150
+85%
|
94
-37%
|
89
-5%
|
96
+7%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
6
|
6
|
6
|
1
|
1
|
|
| Accrued Liabilities |
0
|
1
|
3
|
9
|
4
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
7
|
9
|
16
|
4
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
29
|
30
|
31
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
7
+1 033%
|
9
+29%
|
45
+413%
|
34
-24%
|
36
+4%
|
|
| Equity | |||||||
| Common Stock |
7
|
97
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
6
|
23
|
55
|
150
|
196
|
240
|
|
| Additional Paid In Capital |
0
|
0
|
196
|
200
|
251
|
301
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
74
+5 600%
|
141
+90%
|
49
-65%
|
55
+12%
|
60
+10%
|
|
| Total Liabilities & Equity |
2
N/A
|
81
+4 158%
|
150
+85%
|
94
-37%
|
89
-5%
|
96
+7%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
23
|
23
|
23
|
23
|
42
|
59
|
|
| Preferred Shares Outstanding |
33
|
67
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
